Skip to main content
  • Cranial Nerve Function Before and After Stereotactic Radiosurgery for Cavernous Sinus Meningiomas: A Twenty-three Year Assessment

    Final Number:
    184

    Authors:
    Hideyuki Kano MD PhD; Kyung-Jae Park MD; Aditya K. Iyer BA, MEng; Ajay Niranjan MD MBA; John Flickinger MD; Douglas Kondziolka MD MSc FRCS(C) FACS; L. Dade Lunsford MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: To evaluate cranial nerve outcomes in patients who undergo stereotactic radiosurgery (SRS) for cavernous sinus meningiomas.

    Methods: During a 23-year interval, 303 patients underwent Gamma Knife SRS for skull base meningiomas located in the cavernous sinus. There were 81 males and 222 females with a median age of 56 years (range, 15-86 years). The median tumor volume was 8.0 cc (range, 0.1-43.1 cc). The median marginal dose was 13 Gy (10-20 Gy). The median follow-up period was 60 months (6-212 months).

    Results: In this series, 103 (91%) of 113 patients who underwent prior surgical resection had cranial nerve dysfunction at the time of SRS. In comparison 74 (39%) of 190 patients who had not undergone prior surgical resection had cranial nerve dysfunction. The median duration of cranial nerve dysfunction before SRS was 8 months (range, 0.5-274 months). The progression-free survival after SRS was 92% and 85 % at 5 and 10 years, respectively. Sixty-eight (26%) of 258 patients with cranial nerve dysfunction and clinical follow-up had improvement in cranial nerve function. Using Kaplan-Meier analysis, the improvement rate of cranial nerve dysfunction in patients with prior surgical resection was 8%, 13%, and 15% at 1, 3, and 5 years, respectively. The improvement rate of cranial nerve dysfunction in patients without prior resection was 17%, 33%, and 35% at 1, 3, and 5 years, respectively. Tumor volume, margin dose, age, and symptom duration were not associated with improvement of cranial nerve dysfunction. Forty three patients (14%) developed new or worsening of cranial nerve function; eight had tumor progression and seven had adjacent tumor related brain edema or adverse radiation effect.

    Conclusions: Stereotactic radiosurgery provided effective tumor control with a low risk of new cranial nerve dysfunction. Improvement in preexisting cranial neuropathy was noted in one-fourth of these patients.

    Patient Care: A knowledge of cranial nerve outcomes in patients with cavernous sinus meningioma after stereotactic radiosurgery.

    Learning Objectives: By the conclusion of this session, participants should understand the long term outcomes of SRS for cavernous sinus meningioma.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy